Amgen, Inc. lobbies on its own behalf. For Q3 2026 it reported $3.15M across 1 client report and lists 13 lobbyists across its filings. Issues include Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid and Tariff (miscellaneous tariff bills).
| Client | Reported | Issues |
|---|---|---|
| AMGEN INC | $3.15M | Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $8.17M | 1 |
| 2025 | $13.29M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.